Seattle Genetics Highlights ADCETRIS (Brentuximab Vedotin) Clinical...

Seattle Genetics, Inc. today highlighted multiple ADCETRIS data presentations at the 12th International Conference on Malignant Lymphoma being held June 19-22, 2013 in Lugano, Switzerland.

http://www.businesswire.com/news/topix/20130621005124/en